C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/12 (2006.01) A61K 39/00 (2006.01) A61P 35/00 (2006.01) C07K 14/05 (2006.01) C12Q 1/02 (2006.01) C12Q 1/68 (2006.01) G01N 33/574 (2006.01)
Patent
CA 2633131
The present invention provides a novel cancer-associated antigen that can be used in the treatment and diagnosis of cancer. Further, the invention provides amino acid and nucleic acid sequence of the novel antigen, binding proteins, and immuno--conjugates. The invention also relates to diagnostic and therapeutic methods and kits.
La présente invention a pour objet un nouvel antigène associé au cancer qui peut être utilisé dans le traitement et le diagnostic du cancer. De plus, l'invention concerne une séquence d'acides aminés et d'acides nucléiques du nouvel antigène, des protéines de liaison et des immunoconjugués. L'invention concerne aussi des méthodes et des trousses de diagnostic et de thérapeutique.
Chahal Francina C.
Cizeau Jeannick
Macdonald Glen
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Viventia Biotech Inc.
LandOfFree
Novel cancer-associated antigen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel cancer-associated antigen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel cancer-associated antigen will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1697455